BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10585285)

  • 1. IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.
    Gray SG; Yakovleva T; Hartmann W; Tally M; Bakalkin G; Ekström TJ
    Exp Cell Res; 1999 Dec; 253(2):618-28. PubMed ID: 10585285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a.
    Gray SG; Svechnikova I; Hartmann W; O'Connor L; Aguilar-Santelises M; Ekström TJ
    Cytokine; 2000 Jul; 12(7):1104-9. PubMed ID: 10880258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines.
    Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP
    Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
    Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M
    Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
    Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
    Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on the effect of trichostatin A on differentiation of human lung carcinoma cell].
    Wang CT; Meng M
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):927-9. PubMed ID: 17650409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
    Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21waf1/Cip1 partially mediates apoptosis in hepatocellular carcinoma cells.
    Svechnikova I; Ammerpohl O; Ekström TJ
    Biochem Biophys Res Commun; 2007 Mar; 354(2):466-71. PubMed ID: 17239344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest.
    Li GC; Zhang X; Pan TJ; Chen Z; Ye ZQ
    Int J Urol; 2006 May; 13(5):581-6. PubMed ID: 16771729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichostatin A cooperates with Fas-mediated signal to induce apoptosis in rheumatoid arthritis synovial fibroblasts.
    Morinobu A; Wang B; Liu J; Yoshiya S; Kurosaka M; Kumagai S
    J Rheumatol; 2006 Jun; 33(6):1052-60. PubMed ID: 16755652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
    Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
    Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells.
    Eickhoff B; Rüller S; Laue T; Köhler G; Stahl C; Schlaak M; van der Bosch J
    Biol Chem; 2000 Feb; 381(2):107-12. PubMed ID: 10746741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.